Does the patent value of green technology affect its transfer? The moderating role of industry competition.

Green technology transfer can improve the economic benefits accrued by firms and promote regional green development. Patent value can comprehensively reflect the development prospects of green patents and is an important indicator for predicting green technology transfer. In order to explore the impact of patent value on green technology transfer, this study used a sample of 16,169 green technology patents from Chinese manufacturing industry, which were analyzed using the binary logistic regression model. The results suggest that the technical and economic value of green technology patent positively impact green technology transfer, while the effect of legal value is opposite. Industry competition strengthens the negative impact of the legal value of green technology patents on green technology transfer and weakens the positive impact of green technology patent's economic value. This study explores the factors impacting firms' green technology transfer from a value perspective and proposes suggestions for the transformation of green technology in firms.

Measuring the economic value of community nursing.

The economic value of community nursing is not well understood, meaning it can be a challenge to make the case for investment in the service. The breadth of the service is so vast that it can be difficult to define all the activity and measure the outcomes achieved, which is essential to assess value. A roundtable, hosted by the Healthcare Financial Management Association, considered the challenge of measuring economic value in community nursing, to identify where further work is needed. Community nursing has a key role to play in the development of integrated care systems, as it demonstrates the integration of services at a patient level. Assessment of value needs to recognise the part that the service should play in an integrated care system. However, investment and cultural change is needed within community nursing to ensure activity data is recorded accurately to enable value to be assessed.

The Value(s) of Vaccination: Building the Scientific Evidence According to a Value-Based Healthcare Approach.

Objectives: To provide a new value-based immunization approach collating the available scientific evidence on the topic. Methods: Four value pillars (personal, allocative, technical, and societal) applied to vaccination field were investigated. A systematic literature review was performed querying three database from December 24th, 2010 to May 27th, 2020. It included studies on vaccine-preventable diseases (VPDs) that mentioned the term value in any part and which were conducted in advanced economies. An in-depth analysis was performed on studies addressing value as key element. Results: Overall, 107 studies were considered. Approximately half of the studies addressed value as a key element but in most of cases (83.3%) only a single pillar was assessed. Furthermore, the majority of papers addressed the technical value by looking only at classical methods for economic assessment of vaccinations whereas very few dealt with societal and allocative pillars. Conclusions: Estimating the vaccinations value is very complex, even though their usefulness is certain. The assessment of the whole value of vaccines and vaccinations is still limited to some domains and should encompass the wider impact on economic growth and societies.

Influenza Vaccination Assessment according to a Value-Based Health Care Approach.

BACKGROUND: Seasonal influenza has a considerable public health impact, and vaccination is the key to preventing its consequences. Our aim was to describe how the value of influenza vaccination is addressed in the scientific literature considering a new value framework based on four pillars (personal, allocative, technical, and societal value). METHODS: A systematic review was conducted by querying three databases. The analysis was performed on international studies focused on influenza vaccination value, and the four value pillars were taken into consideration for their description. RESULTS: Overall, 40 studies were considered. Most of them focused on influenza vaccination in the general population (27.5%), emphasizing its value for all age groups. Most studies addressed technical value (70.4%), especially in terms of economic models and cost drivers to be considered for the economic evaluations of influenza vaccines, and societal value (63%), whereas few dealt with personal (37%) and allocative values (22.2%). CONCLUSIONS: The whole value of influenza vaccination is still not completely recognized. Knowledge and communication of the whole value of influenza vaccination is essential to guide value-based health policies. To achieve this goal, it is necessary to implement initiatives that involve all relevant stakeholders.